The GLP-1 Receptor Agonist Semaglutide for the Treatment of Nonalcoholic Steatohepatitis. Dichtel LE. Hepatology 2021 May 6. doi: 10.1002/hep.31886.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dichtel LE. The GLP-1 Receptor Agonist Semaglutide for the Treatment of Nonalcoholic Steatohepatitis. Hepatology 2021 May 6. doi: 10.1002/hep.31886.
PMID: 33960005